文献速递前列腺增生与排尿功能障碍

良性前列腺增生相关下尿路症状管理趋势:2004至2013年美国泌尿疾病项目分析

Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project.
PubMed 文献 · J Urol · 2019-08-20

基于Optum医保索赔数据库(40-64岁男性)和Medicare 5%样本(65岁及以上男性),分析2004至2013年良性前列腺增生相关下尿路症状的药物治疗与手术趋势。结果显示药物治疗随年龄增长而增加,尤其在40-60岁男性中;随时间推移药物治疗增加而手术减少;年轻男性更倾向于选择优化性功能的治疗。

要点

  • 药物治疗随年龄增长而增加,尤其在40-60岁男性中更为明显
  • 研究期间药物治疗使用增加,而外科手术减少
  • 年轻男性更倾向于选择 reportedly 优化性功能的治疗

核心结论

  • 研究期间药物治疗增加而手术减少,治疗方式因年龄差异很大。
  • 年轻男性更可能选择微创手术选项。

研究设计与样本

  • 使用Optum Clinformatics Data Mart数据库(40-64岁男性)和Medicare 5%样本(65岁及以上男性)。
  • 创建年度横断面队列和纵向队列( incident 下尿路症状/良性前列腺增生患者,随访5年)。

主要发现

  • 药物治疗随年龄增长而增加,尤其在40-60岁男性中。
  • 药物治疗随时间增加,手术 procedure 减少。
  • 纵向队列中年龄增长与手术率更高相关。
  • 年轻男性更可能选择 reportedly 优化性功能的治疗。

临床怎么用

  • 临床决策应考虑年龄特异性治疗选择,年轻男性更重视性功能保留。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our current understanding of recent trends in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia is incomplete, particularly in younger men. The 2018 Urologic Diseases in America Project attempted to fill this gap by analyzing multiple large administrative claims databases which include men of all ages and permit longitudinal followup. To our knowledge we report these findings for the first time in the scientific literature. MATERIALS AND METHODS: The 2 data sources used in this study included the de-identified Optum® Clinformatics® Data Mart database for men 40 to 64 years old and the Medicare 5% Sample for men 65 years old or older. To assess trends in lower urinary tract symptoms/benign prostatic hyperplasia related medication prescriptions and surgical procedures from 2004 to 2013 we created annual cross-sectional cohorts and a longitudinal cohort of patients with incident lower urinary tract symptoms/benign prostatic hyperplasia and 5 years of followup. RESULTS: The use of medications related to lower urinary tract symptoms/benign prostatic hyperplasia increased with age, particularly among men 40 to 60 years old. While medication use increased with time, surgical procedures decreased. Increasing age correlated with a higher rate of surgical procedures in the longitudinal cohort. Younger men were more likely to elect treatments of lower urinary tract symptoms/benign prostatic hyperplasia which reportedly optimize sexual function. CONCLUSIONS: Medication use increased and surgery decreased during the study period. Treatment approaches to lower urinary tract symptoms/benign prostatic hyperplasia varied greatly by patient age. While the minority of men in the fifth and sixth decades of life required treatment, a sharp increase in treatment use was seen between these decades. Younger men were more likely to elect less invasive surgical options. Future studies of lower urinary tract symptoms/benign prostatic hyperplasia should focus on age specific treatment selection.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Welliver C, Feinstein L, Ward JB, et al. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project. J Urol. 2019. PMID: 31430232. doi:10.1097/JU.0000000000000499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。